New Baoli Financing (08439.HK) reports a profit, expecting a mid-term post-tax profit of approximately 200,000 Hong Kong dollars and turning a loss into a profit year-on-year.

The Zhongtong Financial News APP reported that Sing Biotech Finance (08439.HK) announced that the group is expected to achieve a post-tax profit of approximately HK$200,000 for the six months ending September 30, 2025 (compared to a post-tax loss of approximately HK$11.7 million in 2024).